Aplastic Anemia is a rare and serious blood disorder characterized by a failure of the bone marrow to produce an adequate number of blood cells. Stem cells in the bone marrow are damaged or suppressed, leading to low counts of red blood cells, white blood cells, and platelets. Common symptoms include fatigue, weakness, shortness of breath, pale skin, frequent infections, and easy bruising or bleeding. Diagnosis involves blood tests and a bone marrow biopsy to assess cell counts and identify potential causes. Treatment options include blood transfusions, medications to stimulate bone marrow function, and immunosuppressive therapy. In severe cases, a bone marrow transplant may be considered. Prognosis varies, and ongoing medical monitoring and supportive care are often necessary. Aplastic Anemia can be acquired or inherited, with acquired forms often idiopathic or associated with factors like drug exposure, toxins, infections, or autoimmune disorders. Managing this complex condition requires a multidisciplinary approach involving hematologists and other specialists.
Title : The effect of OTC N-acetyl-cysteine on cobaltemia and cobalturia from cobalt-chromium orthopedic implants
Stephen S Tower, University of Alaska Anchorage, United States
Title : A data driven approach to prehabilitation and rehabilitation for hip and knee replacement patients
Diana Hodgins, Dynamic Metrics Ltd, United Kingdom
Title : Selective denervation for persistent knee pain after total knee arthroplasty: Long-term outcomes
Shaomin Shi, Medical College of Wisconsin, United States
Title : The etiological diagnosis of torticollis
Ali Al Kaissi, Ilizarov Institute, Austria
Title : Acute Traumatic Spinal Cord Injuries(TSCI) – Is the current standard of care evidence based?
W S El Masri, Keele University, United Kingdom
Title : AI-Driven infrared imaging and telerobotics in orthopedics: Enhancing diagnostics, surgical precision, and postoperative care
Marcos Brioschi, American Academy of Thermology, United States